Home
About
FAQ
History (12)
Virginiamycin
Canavalia
Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis.
Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study.
microRNAs: fad or future of liver disease.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
microRNAs: fad or future of liver disease.
Lakner AM, Bonkovsky HL, Schrum LW. microRNAs: fad or future of liver disease. World J Gastroenterol. 2011 May 28; 17(20):2536-42.
View in:
PubMed
subject areas
Animals
Fatty Liver
Humans
Liver Cirrhosis
Liver Diseases
Liver Regeneration
MicroRNAs
authors with profiles
Herbert L. Bonkovsky MD